SP
TMO icon

Symmetry Partners’s Thermo Fisher Scientific TMO Stock Holding History

Symmetry Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,368
Closed -$1.31M – 464
2024
Q2 		$1.31M Sell
2,368
-142
-6% -$81.3K 0.07% 127
2024
Q1 		$1.46M Hold
2,510
– – 0.11% 126
2023
Q4 		$1.34M Sell
2,510
-642
-20% -$311K 0.07% 130
2023
Q3 		$1.59M Sell
3,152
-261
-8% -$139K 0.09% 111
2023
Q2 		$1.78M Sell
3,413
-111
-3% -$59.9K 0.09% 106
2023
Q1 		$2.03M Hold
3,524
– – 0.11% 98
2022
Q4 		$1.94M Sell
3,524
-226
-6% -$120K 0.11% 98
2022
Q3 		$1.9M Hold
3,750
– – 0.13% 89
2022
Q2 		$2.04M Sell
3,750
-315
-8% -$173K 0.14% 82
2022
Q1 		$2.4M Buy
4,065
+315
+8% +$181K 0.15% 78
2021
Q4 		$2.5M Hold
3,750
– – 0.16% 82
2021
Q3 		$2.15M Hold
3,750
– – 0.14% 93
2021
Q2 		$1.89M Hold
3,750
– – 0.13% 106
2021
Q1 		$1.71M Sell
3,750
-464
-11% -$221K 0.12% 112
2020
Q4 		$1.96M Sell
4,214
-909
-18% -$426K 0.15% 88
2020
Q3 		$2.26M Buy
5,123
+3,943
+334% +$1.63M 0.19% 75
2020
Q2 		$428K Buy
1,180
+110
+10% +$36.9K 0.05% 178
2020
Q1 		$303K Sell
1,070
-3,992
-79% -$1.26M 0.07% 206
2019
Q4 		$1.64M Sell
5,062
-614
-11% -$186K 0.34% 43
2019
Q3 		$1.65M Hold
5,676
– – 0.34% 43
2019
Q2 		$1.67M Buy
5,676
+177
+3% +$48.8K 0.34% 46
2019
Q1 		$1.5M Buy
5,499
+1,586
+41% +$395K 0.26% 54
2018
Q4 		$876K Buy
+3,913
New +$918K 0.22% 65

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Symmetry Partners's TMO Position: Q3 2024 in Review

Symmetry Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 2,368 shares — an estimated $1.31M sold.

Symmetry Partners first reported a position in TMO in Q4 2018 and held it in 23 quarters. The position peaked at $2.5M in Q4 2021. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Symmetry Partners reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 2,368 Thermo Fisher Scientific shares in Q3 2024, an estimated $1.31M.
  • Symmetry Partners first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 23 quarters.
  • Symmetry Partners's Thermo Fisher Scientific position peaked at $2.5M in Q4 2021.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.